These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

302 related items for PubMed ID: 15465144

  • 1. Clinical and physical determinants for toxicity of 125-I seed prostate brachytherapy.
    Wust P, von Borczyskowski DW, Henkel T, Rosner C, Graf R, Tilly W, Budach V, Felix R, Kahmann F.
    Radiother Oncol; 2004 Oct; 73(1):39-48. PubMed ID: 15465144
    [Abstract] [Full Text] [Related]

  • 2. Acute genitourinary toxicity after high-dose-rate (HDR) brachytherapy combined with hypofractionated external-beam radiation therapy for localized prostate cancer: correlation between the urethral dose in HDR brachytherapy and the severity of acute genitourinary toxicity.
    Akimoto T, Ito K, Saitoh J, Noda SE, Harashima K, Sakurai H, Nakayama Y, Yamamoto T, Suzuki K, Nakano T, Niibe H.
    Int J Radiat Oncol Biol Phys; 2005 Oct 01; 63(2):463-71. PubMed ID: 16168838
    [Abstract] [Full Text] [Related]

  • 3. Prospective assessment of patient-reported long-term urinary morbidity and associated quality of life changes after 125I prostate brachytherapy.
    Stone NN, Stock RG.
    Brachytherapy; 2003 Oct 01; 2(1):32-9. PubMed ID: 15062161
    [Abstract] [Full Text] [Related]

  • 4. Factors predicting for urinary incontinence after prostate brachytherapy.
    McElveen TL, Waterman FM, Kim H, Dicker AP.
    Int J Radiat Oncol Biol Phys; 2004 Aug 01; 59(5):1395-404. PubMed ID: 15275725
    [Abstract] [Full Text] [Related]

  • 5. Intraoperative real-time planned conformal prostate brachytherapy: post-implantation dosimetric outcome and clinical implications.
    Zelefsky MJ, Yamada Y, Cohen GN, Sharma N, Shippy AM, Fridman D, Zaider M.
    Radiother Oncol; 2007 Aug 01; 84(2):185-9. PubMed ID: 17692978
    [Abstract] [Full Text] [Related]

  • 6. Combined brachytherapy with external beam radiotherapy for localized prostate cancer: reduced morbidity with an intraoperative brachytherapy planning technique and supplemental intensity-modulated radiation therapy.
    Zelefsky MJ, Nedelka MA, Arican ZL, Yamada Y, Cohen GN, Shippy AM, Park JJ, Zaider M.
    Brachytherapy; 2008 Aug 01; 7(1):1-6. PubMed ID: 18299108
    [Abstract] [Full Text] [Related]

  • 7. Acute genitourinary toxicity after high dose rate (HDR) brachytherapy combined with hypofractionated external-beam radiation therapy for localized prostate cancer: Second analysis to determine the correlation between the urethral dose in HDR brachytherapy and the severity of acute genitourinary toxicity.
    Akimoto T, Katoh H, Noda SE, Ito K, Yamamoto T, Kashiwagi B, Nakano T.
    Int J Radiat Oncol Biol Phys; 2005 Oct 01; 63(2):472-8. PubMed ID: 16168839
    [Abstract] [Full Text] [Related]

  • 8. Predictive factors for acute and late urinary toxicity after permanent prostate brachytherapy: long-term outcome in 712 consecutive patients.
    Keyes M, Miller S, Moravan V, Pickles T, McKenzie M, Pai H, Liu M, Kwan W, Agranovich A, Spadinger I, Lapointe V, Halperin R, Morris WJ.
    Int J Radiat Oncol Biol Phys; 2009 Mar 15; 73(4):1023-32. PubMed ID: 19111402
    [Abstract] [Full Text] [Related]

  • 9. Initial comparison of inverse optimization, modified peripheral technique, and geometric optimization as real-time intraoperative computer planning options for permanent seed implantation of the prostate.
    Raben A, Sammons S, Sim S, Chen H, Hanlon A, Sarkar A, Donavanik V, Grebler A, Geltzeiler J, Benge B, Glick A, Jacob D, Koprowski P.
    Brachytherapy; 2007 Mar 15; 6(4):238-45. PubMed ID: 17991621
    [Abstract] [Full Text] [Related]

  • 10. [Acute adverse effects of high dose brachytherapy in combination with external radiotherapy in localized prostate cancer].
    Soumarová R, Homola L, Stursa M, Perková H.
    Cas Lek Cesk; 2006 Mar 15; 145(1):43-9. PubMed ID: 16468241
    [Abstract] [Full Text] [Related]

  • 11. Segmental dosimetry, toxicity and long-term outcome in patients with prostate cancer treated with permanent seed implants.
    Meyer A, Wassermann J, Warszawski-Baumann A, Baumann R, Machtens S, Karstens JH, Christiansen H, Merseburger A, Kuczyk MA, von Klot C.
    BJU Int; 2013 May 15; 111(6):897-904. PubMed ID: 23305079
    [Abstract] [Full Text] [Related]

  • 12. Intraoperative conformal optimization for transperineal prostate implantation using magnetic resonance spectroscopic imaging.
    Zelefsky MJ, Cohen G, Zakian KL, Dyke J, Koutcher JA, Hricak H, Schwartz L, Zaider M.
    Cancer J; 2000 May 15; 6(4):249-55. PubMed ID: 11038145
    [Abstract] [Full Text] [Related]

  • 13. Favorable toxicity and biochemical control using real-time inverse optimization technique for prostate brachytherapy.
    Raben A, Rusthoven KE, Sarkar A, Glick A, Benge B, Jacobs D, Raben D.
    Brachytherapy; 2009 May 15; 8(3):297-303. PubMed ID: 19213608
    [Abstract] [Full Text] [Related]

  • 14. Dose-volume impact in high-dose-rate Iridium-192 brachytherapy as a boost to external beam radiotherapy for localized prostate cancer--a phase II study.
    Pinkawa M, Fischedick K, Treusacher P, Asadpour B, Gagel B, Piroth MD, Borchers H, Jakse G, Eble MJ.
    Radiother Oncol; 2006 Jan 15; 78(1):41-6. PubMed ID: 16271785
    [Abstract] [Full Text] [Related]

  • 15. [Quality of life after radiotherapy for prostate cancer].
    Joly F, Degrendel AC, Guizard AV.
    Cancer Radiother; 2010 Oct 15; 14(6-7):519-25. PubMed ID: 20728393
    [Abstract] [Full Text] [Related]

  • 16. Dose-volume conundrum for response of prostate cancer to brachytherapy: summary dosimetric measures and their relationship to tumor control probability.
    D'Souza WD, Thames HD, Kuban DA.
    Int J Radiat Oncol Biol Phys; 2004 Apr 01; 58(5):1540-8. PubMed ID: 15050335
    [Abstract] [Full Text] [Related]

  • 17. Volume and hormonal effects for acute side effects of rectum and bladder during conformal radiotherapy for prostate cancer.
    Peeters ST, Hoogeman MS, Heemsbergen WD, Slot A, Tabak H, Koper PC, Lebesque JV.
    Int J Radiat Oncol Biol Phys; 2005 Nov 15; 63(4):1142-52. PubMed ID: 15939547
    [Abstract] [Full Text] [Related]

  • 18. Acute toxicity of conformal high dose interstitial brachytherapy boost in prostate cancer.
    Soumarová R, Homola L, Stursa M, Perková H.
    Neoplasma; 2006 Nov 15; 53(5):410-7. PubMed ID: 17013535
    [Abstract] [Full Text] [Related]

  • 19. [Combination of bilateral pelvic lymphadenectomy, permanent iodine-125 implantation and percutaneous irradiation of localized prostate carcinoma. 2: Discussion and conclusions].
    Thiel HJ, Müller R, Schrott KM.
    Strahlenther Onkol; 1987 Mar 15; 163(3):176-84. PubMed ID: 3105102
    [Abstract] [Full Text] [Related]

  • 20. Permanent 125I-seed brachytherapy or radical prostatectomy: a prospective comparison considering oncological and quality of life results.
    Borchers H, Kirschner-Hermanns R, Brehmer B, Tietze L, Reineke T, Pinkawa M, Eble MJ, Jakse G.
    BJU Int; 2004 Oct 15; 94(6):805-11. PubMed ID: 15476513
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 16.